INTRODUCTION
============

Depletion of finite liquid fuels is on the horizon, and the growing concern with current energy and environmental problems has ignited an interest in the production of liquid biofuels ([@B51]; [@B104]; [@B36]). In 2010, petroleum consumption in the United States was about 36 quadrillion BTU, in which 70% consumed was imported ([@B37]). To help increase independence from petroleum-derived fuels as well as its foreign importation, endeavors to develop and improve biological methods to produce renewable liquid fuels are in play ([@B94]; [@B39]; [@B65]; [@B88]). Ethanol ranks as the most prominent biofuel to date, reaching a production high of 13.2 billion gallons in 2010 (more than eight times produced a decade ago; [@B37]). Despite its well-developed production and wide use, notably as a gasoline additive and as a high-percentage E85 blend, it falls short of being the ideal "drop-in" fuel to replace gasoline. Ethanol is hygroscopic, making it incompatible with current gasoline infrastructure. Moreover, ethanol is only 65% as energy dense as gasoline (20.8 versus 32.0 MJ/L, respectively; [@B67]). Higher-chain alcohols, on the other hand, are not hygroscopic, and provide energy densities that are more comparable to gasoline, and thus help to mitigate the problems that ethanol arises.

Unlike ethanol, higher-chain alcohols (except 1-butanol produced naturally by the *Clostridium* species; [@B56]) are neither produced efficiently in nature nor in efficient quantities, and so increased efforts are being made to use microorganisms to cost-effectively produce them from biomass as well as in industrial volumes. Much energy has been put into using metabolic engineering to improve natural producers of these alcohols in the past, but without success in reaching desired industrial-relevant titers and productivity ([@B71]). Part of this difficulty stems from a lack of tools and techniques for genetic modification, slow growth, and complex physiology of the natural producer ([@B35]). User-friendly hosts such as *Escherichia coli* and *Saccharomyces cerevisiae*, however, come with a wide range of tools and techniques, are faster growing, and possess a more simple physiology. With these helping hands, many efforts have been put into developing higher-chain alcohol production in non-native hosts.

Outside the advantageous inherent properties of using a well-characterized host and the ease in which metabolic engineering can help optimize pathways and maintain cell fitness, synthetic biology is a relatively nascent practice being used to aid in the development of higher-chain alcohol producers ([@B1]; [@B59]). Synthetic biology provides the ability to piece together biological components from several different origins in order to redesign a natural or construct a novel pathway that the host uses to synthesize a valuable chemical ([@B58]; [@B22]). In conjunction with metabolic engineering, development of a more efficient production platform in a non-native but user-friendly host for a desired chemical is made possible ([@B2]). This review will concentrate on recent progress in using synthetic biology to engineer user-friendly microbes that produce C3--C10 alcohols.

CoA-DEPENDENT PATHWAYS
======================

Natural production of 1-butanol occurs in the acetone--butanol--ethanol (ABE) pathway of the *Clostridium* species ([@B42]), where starch and simple sugars are fermented into a mixture of solvents, including acetone, lactate, and acetoin. In this pathway, two acetyl-CoA molecules are converted to butyryl-CoA in four enzymatic steps using acetyl-CoA acetyltransferase, 3-hydroxybutyryl-CoA dehydrogenase, crotonase, and butyryl-CoA dehydrogenase ([@B14]). From here, 1-butanol can be produced using a dual-function butyraldehyde/butanol dehydrogenase ([@B6]).

Since natural alcohol producers like the *Clostridium* species have been difficult to engineer for 1-butanol production, great strides have been made to transfer and improve this traditional fermentation pathway in non-natural producers like *E. coli* and *S. cerevisiae*. For example, *E. coli*, a Gram-negative bacterium, has a long history of being studied and exploited as a model host, due to its rapid growth rate, relatively simple physiology and nutritional needs, as well as ease of cultivation and manipulation. Furthermore, elucidation and characterization of its genetics, physiology, and biochemistry has led to the development of a wide selection of genetic tools for manipulating cell behavior and function.

In general, overexpression of either native or heterologous genes involves construction of plasmids that fuse multiple genes transcriptionally. Overexpression of genes may also be integrated into the genomic DNA (gDNA) of a microorganism using homologous recombination via a plasmid containing the gene of interest and a selectable marker. This approach is used to engineer cyanobacteria such as *Synechococcus elongatus*([@B43]). Furthermore, in order to gain control of expression levels, there are various promoters, both native and engineered ([@B45]; [@B17]; [@B96]; [@B33]; [@B80]; [@B72]; [@B49]; [@B82]), available to choose from. While heterologous gene expression -- due to various factors like protein misfolding and aggregation ([@B98]; [@B99]) -- is not always successful, progress has been made to mechanistically understand why these processes can occur ([@B41]; [@B12]; [@B4]). As a result, several approaches have been developed to circumvent these types of pitfalls and increase the likelihood that heterologous expression is successful ([@B12]).

To minimize costs for industrial scale production, it is ideal that production can be done in minimum growth media rather than rich media. More often than not, however, rich media are used in order to maximize cell density and optimize cell condition for production in laboratory scale production ([@B97]; [@B3]). Measurement of alcohols and other metabolites can be monitored using various chromatographic methods, typically gas chromatography--mass spectrometry (GC--MS), gas chromatography--flame ionization detector (GC--FID), and high-performance liquid chromatography (HPLC).

The following describes research to increase the titers of 1-butanol, isopropanol, and 1-hexanol in user-friendly hosts, as well as the utilization and engineering of the CoA-dependent pathway (**Figure [1](#F1){ref-type="fig"}**) to shunt production toward non-natural higher-chain alcohols.

![**Metabolic representation of CoA-dependent pathways for biofuel production**. G3P, glyceraldehyde-3-phosphate; 3PG, 3-phosphoglycerate; ACoAAT, acetyl-CoA acetyltransferase; BktB, 2-ketothiolase; Hbd, 3-hydroxybutyryl-CoA; Crt, crotonase; Bcd, butyryl-CoA dehydrogenase; Etf, electron transfer flavoprotein; ACoAT, acetoacetyl-CoA transferase; ADC, acetoacetate decarboxylase; AdhE2, aldehyde/alcohol dehydrogenase; SADH, primary--secondary alcohol dehydrogenase. Reversal of β-oxidation to make -alcohols (in the presence of a non-fatty acid carbon source) is indicated in brackets.](fmicb-03-00196-g001){#F1}

1-BUTANOL PRODUCTION
====================

In order to demonstrate the feasibility of this strategy, [@B6] transferred the 1-butanol pathway of *Clostridium acetobutylicum* into *E. coli*. Use of 1-butanol as an additive or replacement for gasoline has been growing in popularity due to its hygroscopicity and comparable energy density (29.2 MJ/L) to gasoline. For production through the *Clostridium* pathway, one 1-butanol molecule is produced per molecule of glucose and four NADH. The strain containing essential genes for 1-butanol production (*thl*, *hbd*, *crt*, *bcd*, *etfAB*, and *adhE2*) were cloned and expressed using a two-plasmid system, where *thl* and *adhE2* were overexpressed under control of the IPTG-inducible P~L~lacO~1~ promoter ([@B72]) in a colE ([@B57]) origin plasmid, while *crt*, *bcd*, *etfAB*, and *hbd* were overexpressed under control of the P~L~lacO~1~ promoter in a p15A ([@B20]) replication origin plasmid. This two-plasmid expression strain produced 13.9 mg/L 1-butanol in 40 h under anaerobic conditions. Elevating oxygen levels increased production in this strain, although these enzymes are from a strict anaerobe. To further improve production, genes responsible for production of metabolic byproducts in the *E. coli* genome were deleted. Namely, Δ*ldhA*, Δ*frdBC*, and Δ*adhE* knockouts were introduced in order to reduce lactate, ethanol, and succinate. Furthermore, *pta* (encoding phosphotransacetylase) was deleted to decrease amount of acetate produced. The *fnr* gene, encoding the regulator Fnr that deactivates the pyruvate dehydrogenase complex under anaerobic conditions, was deleted as well. The resulting strain boosted 1-butanol production to 373 mg/L. Finally, this strain, when grown in Terrific Broth (TB)-enriched, glycerol-supplemented media ([@B97]), increased 1-butanol titer to 552 mg/L.

A promising strategy to tweak alcohol production further in non-native hosts is to consider the various driving forces that are modified as a consequence to manipulating a host, and making efforts to alleviate negative affects in a resulting strain. When altering a native pathway, many factors such as growth and gene expression have the potential to be compromised, which can diminish cell fitness and create bottlenecks in the engineered system that prevent high titers of a desired product ([@B38]). A recurring problem that must be tackled is the ubiquitous occurrence of reversible reactions in metabolic pathways that slow the optimal production of important intermediates essential for propelling a series of steps.

[@B16] explored the chemical nature of enzymes to drive equilibria forward in the design of a 1-butanol platform in *E. coli*. First, in an *E. coli* strain containing *phaA*, *phaB*, and *crt* in a p15A origin ([@B20]) plasmid, and *ccr* and *adhE2* in a colE origin ([@B57]) plasmid (both under control of the IPTG-inducible P~trc~ promoter; [@B17]), only 95 mg/L 1-butanol was produced after 6 days in TB supplemented with glucose. To push the equilibrium between crotonyl-CoA and butyryl-CoA forward, *ter*, encoding an NADH-dependent crotonyl-CoA reductase from *Treponema denticola*, replaced *ccr*. This gene replacement led to a 3.5-fold increase in titer (340 mg/L) after 3 days. Upon further investigation for additional bottlenecks, enzymes that generate stereo-specific products were found and tested. After replacing *phaB* with *hbd*, encoding NADH-dependent (*S*)-3-hydroxybutyryl-CoA dehydrogenase from *C. acetobutylicum*, and *crt* with *phaJ*, encoding an R-specific enoyl-CoA hydratase from *Aeromonas caviae*, production rose to 2.95 g/L. Finally, balance of reducing equivalents was taken into consideration. While four NADH molecules needed to make one molecule 1-butanol, glycolysis only produces two NADH per glucose molecule. To increase availability and direct consumption of acetyl-CoA and NADH toward alcohol production and away from lactate and acetate formation, *aceEF-lpd*, encoding the pyruvate dehydrogenase complex, was overexpressed. This enhancement provided the additional two NADH molecules needed to synthesize 1-butanol, and improved production levels to a final titer of 4.65 g/L at 28% the theoretical max from glucose.

Using a similar premise to improve the CoA-dependent pathway in *E. coli*, [@B89] utilized a number of driving forces to generate 1-butanol in industrial-relevant quantities. In this study, *atoB* (*E. coli*), *adhE2* (*C. acetobutylicum*), *crt* (*C. acetobutylicum*), *hbd* (*C. acetobutylicum*), and *ter* (*T. denticola*; used to replace the oxygen-sensitive, NADPH-dependent Bcd--EtfAB complex) genes were overexpressed in an *E. coli* Δ*adhE* Δ*ldhA* Δ*frd* strain (JC166), which cannot grow without an additional NADH-consuming pathway. In this two-plasmid system, *atoB*, *adhE2*, *crt*, and *hbd* were overexpressed in a plasmid under control of the P~L~lacO~1~ promoter ([@B72]) with a colE ([@B57]) origin, while *ter* was overexpressed in a plasmid under P~L~lacO~1~ control with a colA origin ([@B105]). This strain anaerobically produced 1.8 g/L after 24 h in TB supplemented with glucose. Catalysis by Ter to convert crotonyl-CoA to butyryl-CoA was found irreversible in the presence of excess butyryl-CoA and NAD^+^ by *in vitro* enzyme assays. Furthermore, Bcd--EtfAB replacement by NADH-dependent Ter successfully restored anaerobic growth of JC166. Next, *fdh*, encoding a formate dehydrogenase from *Candida boidinii*, was overexpressed to reduce excess pyruvate. Without overexpression of *fdh* in the 1-butanol pathway, pyruvate serves as a sink for excess carbon flux and piles up in the cell. On the contrary, when *fdh* is overexpressed, formate is oxidized into CO~2~ and NADH to promote accumulation of the additional two NADH equivalents needed for 1-butanol production. Moreover, *pta*, which would have encoded a phosphate acetyltransferase, was deleted in order to build up acetyl-CoA and decrease acetate formation. As a result, 1-butanol production rose to 15 g/L after 3 days at 88% theoretical maximum yield. Lastly, anaerobic, pH-controlled fermentation was performed, in conjunction with continuous gas stripping, using a 1 L stirred-tank bioreactor. Final measurements indicated that 1-butanol levels shot up to 30 g/L after 7 days (\~70% theoretical maximum).

*Escherichia coli* is not the only user-friendly host available to for 1-butanol production. The robust yeast, *S. cerevisiae*, has been a prominent host for industrial ethanol production as well as the non-native production of a variety of valuable chemicals. It is well-characterized, has a wide range of genetic tools for manipulation, its fermentation is relatively cheap, and its mass production and downstream processing is well-developed. Especially,*S. cerevisiae*has a vast history of being used for the production of ethanol for beer and wine from sugars. Like for *E. coli*, synthetic biology has contributed to the improvement of engineered processes in *S. cerevisiae* ([@B63]).

[@B92] chose *S. cerevisiae* as the host for 1-butanol production, in which clostridial enzymes were substituted with isozymes from various other species. From an initial group of strains to elucidate a thiolase with the best activity \[*phaA* (*Ralstonia eutropha*), *atoB* (*E. coli*), or *ERG10* (*S cerevisiae*)\], the highest producer (BY4747) containing *phaA* and *phaB* (*R. eutropha)*, *ccr* (*Streptomyces collinus*), and *crt* and *adhE2* (*C. beijerinckii*), under control of either the GAL1 or GAL10 galactose-dependent promoters in 2 μ origin ([@B53]) plasmids, generated 1 mg/L 1-butanol. To improve upon this initial strain, an NADH-dependent hydroxybutyryl-CoA dehydrogenase, encoded by Hbd, replaced an NADPH-dependent enzyme, encoded by PhaB. The strain including *ERG10* (encoding a native thiolase) and *hbd*resulted in 2.5 mg/L production in synthetic defined (SD) media ([@B3]) supplemented with galactose.

In an interest to compare production in various hosts, [@B81] reconstructed and engineered the 1-butanol pathway of *C. acetobutylicum* into Gram-negative *Pseudomonas putida* and Gram-positive *Bacillus subtilis*. *P. putida* and *B. subtilis* were chosen as hosts for this biosynthetic pathway due to higher 1-butanol tolerance relative to *E coli*([@B25]). *P. putida* has been exploited for bioremediation of soil, and possesses a versatile metabolism, an ability to thrive in extreme environmental conditions, simple nutritional requirements, and rapid growth rate ([@B30]). The *P. putida*strain was cultured in TB under control of the IPTG-inducible T7lac promoter ([@B96]) and produced 50 mg/L with glucose, and 122 mg/L with glycerol. Results also indicated that the Bcd--EtfAB complex of *C. acetobutylicum*was active in the obligate aerobe. *B. subtilis*, on the other hand, has been extensively studied as a model Gram-positive bacterium, and can live in several different environments, including soil, animal gastrointestinal tracts, and plant roots. Moreover, it possesses the distinct ability to become competent for transformation naturally ([@B32]). *B. subtilis* genes *amyE* (encoding an α-amylase), *thrC*(encoding a threonine synthase), and *pyrD* (encoding a dihydroorotate dehydrogenase) were deleted from the genome using double-crossover homologous recombination. The *B. subtilis* Δ*amyE* Δ*thrC* Δ*pyrD*strain was cultured in TB under control of the IPTG-inducible promoter ([@B96]), and produced 23 mg/L with glucose, and 24 mg/L in glycerol under anaerobic conditions.

Production of higher-chain alcohols using bacteria that directly utilize CO~2~ and sunlight is another approach being explored. In addition, if an efficient production platform is successfully designed, then production of higher-chain alcohols directly from sunlight would give a higher-value advantage. One photosynthetic organism with a growing genetic toolbox, elucidated genome sequences, and relatively fast growth rate is known as cyanobacteria ([@B84]), and its capabilities have already been tapped to produce a range of different fuels and chemicals ([@B74]). In cyanobacterial systems, sunlight is utilized to fix carbon in the Calvin--Benson--Bassham cycle and produce intermediates that enter and are consumed in glycolysis. Thus, the need to grow and convert biomass into sugars is bypassed.

[@B64] introduced a 1-butanol pathway into *S. elongatus* PCC 7924 by integrating *atoB* (*E. coli*) and *adhE2* (*C. acetobutylicum*), under P~trc~ control ([@B17]), into neutral site I (NSI; [@B18]), and then integrating *hbd*, *crt* (*C. acetobutylicum*), and *ter* (*T. denticola*), under P~L~lacO~1~ control ([@B72]), into neutral site II (NSII; [@B5]) on the genome ([@B64]). In this strain, 3.04 mg/L 1-butanol accumulated after 7 days. In an improved strain containing gene rearrangement where a His-tagged *ter*was integrated, under P~trc~ control, into NSI, and *atoB*, *adhE2*, *hbd*, and *crt* genes were integrated, under P~L~lacO~1~ control, into NSII, 13.16 mg/L 1-butanol was produced. Cultures in screw-capped flasks and air-bubbling cultures, however, did not produce 1-butanol. To determine whether light or oxygen halted 1-butanol production, various culturing conditions (i.e., oxic/anoxic, light/dark) in BG-11 media supplemented with NaHCO~3~ was tested. Delving further into oxygen effects, photosystem II was inhibited with 3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU; [@B61]), in order to prevent generation of oxygen under light. Between 2.5 and 5.5 mg/L 1-butanol was produced under continuous light and addition of varying concentrations of DCMU, indicating that elimination of oxygen is key for 1-butanol production in *S. elongatus*. Furthermore, experiments to test AdhE2 activity in oxic and anoxic conditions showed similar activities in both conditions, suggesting that low AdhE2 activity may not be related to the anoxic requirement for 1-butanol production. The best strain produced 14.5 mg/L 1-butanol in 7 days while decreasing in cell density (OD~730~ from 3.9 to 2.4) when incubated in dark anoxic conditions.

ISOPROPANOL PRODUCTION
======================

Isopropanol production using the CoA-dependent pathway has also been explored. Even though isopropanol has an energy density of only 23.9 MJ/L, it has a lower hygroscopicity relative to ethanol. With these properties, isopropanol may be used as a gasoline or diesel additive.

[@B50] constructed the isopropanol pathway in *E. coli*, modeling it after the one in *C. beijerinckii* that converts acetyl-CoA via acetone into isopropanol. First, an acetyl-CoA acetyltransferase condenses two acetyl-CoA molecules into acetoacetyl-CoA. Next, an acetoacetyl-CoA transferase is used to form acetoacetate. Then, an acetoacetate decarboxylase is used to produce acetone and CO~2~. Finally, a secondary alcohol dehydrogenase (ADH) reduces acetone into isopropanol. Five combinations of the following genes were overexpressed for production under control of the P~L~lacO~1~ promoter ([@B72]): *atoB* (*E. coli*) or *thl* (*C. acetobultylicum*), *ctfAB* (*C. acetobutylicum*) or *atoAD* (*E. coli*), *adc* (*C. acetobutylicum*), and *adh* (*C. beijerinckii* or *Thermoanaerobacter brockii*). All strains \[except one where overexpression of an *adh* (*T. brockii*), encoding a primary--secondary alcohol (SADH), produced 1.1 g/L acetone\] produced comparable isopropanol titers, ranging between 2.1 and 2.7 g/L, with minute quantities of acetone and ethanol. The strain that produced 2.7 g/L isopropanol overexpressed *adh* in a p15A origin ([@B20]) plasmid, while *thl*, *atoAD*, and *adc* were overexpressed in a colE origin ([@B57]) plasmid. Crude extract assays measured an SADH (*C. beijerinckii*) activity nearly 13 times higher than that of *T. brockii*, thus explaining the stark difference in isopropanol to acetone ratio. Further experiments in SD-8 media ([@B70]), with varied starting amounts of glucose concentration resulted in isopropanol production peaking at 4.9 g/L after 30.5 h. Furthermore, maximum productivity was reported to be 0.41 g/L/h between 3 and 9.5 h at 43.5% theoretical yield.

[@B55] further improved isopropanol production in *E. coli* by optimizing culture and media conditions, as well as using gas stripping for product recovery. First, pH-maintained, intermittent-fed fermentation in SD-8 media ([@B70]) supplemented with glucose resulted in 40.1 g/L isopropanol after 60 h at 73.2% theoretical yield, and a production rate of 0.74 g/L/h between 6 and 60 h. To further increase titer, isopropanol was recovered using a gas-stripping system, where an optimized amount of air was bubbled through the culture in order to remove, transfer, and collect isopropanol and other volatile compounds into two collection bottles. By fusing fed-batch fermentation to the gas-stripping setup, isopropanol concentration increased to 79.6 g/L after 144 h, with a concentration of 19.8 g/L in the culture flask. However, cell density and production rate decreased over time. To alleviate this decrease, concentrated media was intermittently added in order to keep a fresh stock of nutrients available for consumption. Using this approach, titers reached 143 g/L after 240 h at 67.4% maximum theoretical yield, and demonstrated the potential for industrial fermentative production of isopropanol.

1-HEXANOL PRODUCTION
====================

[@B26] expanded the 1-butanol pathway in *E. coli* in order to produce 1-hexanol. The pathway constructed by [@B89] was used as the starting point, where *atoB* (*E. coli*), *adhE2* (*C. acetobutylicum*), *hbd*(*C. acetobutylicum*), and *crt* (*C. acetobutylicum*) were overexpressed in a plasmid under control of the P~L~lacO~1~ promoter ([@B72]) with a colE origin ([@B57]) of replication, and *ter* \[Eg-*ter* (*Euglena gracilis*) or Td-*ter*(*T. denticola*)\] was overexpressed in a plasmid under control of the P~L~lacO~1~ promoter and colA origin ([@B105]) to convert two molecules of acetyl-CoA into butyryl-CoA. Finally, butyryl-CoA is subsequently reduced by AdhE2 (*C. acetobutylicum*) into 1-butanol. In order to extend the potential alcohol by two carbons, *bktB* (*R. eutropha*; encodes a 2-ketothiolase) was overexpressed in a plasmid under control of the P~L~lacO~1~ promoter and colA origin to add an acetyl group to butyryl-CoA to generate 3-keto-hexanoyl-CoA. Similar to synthesis of 1-butanol, 3-keto-hexanoyl-CoA can then be converted to 1-hexanol using the same enzymes used to convert acetoacetyl-CoA. First, Hbd converts 3-keto-hexanoyl-CoA into 3-hydroxyhexanoyl-CoA, allowing Crt to catalyze the generation of hexenoyl-CoA. Next, Ter is used to make hexanoyl-CoA. Finally, alcohol/aldehyde dehydrogenase AdhE2 cleaves the CoA group from hexanoyl-CoA and reduces it into 1-hexanol in two steps. An *E. coli* Δ*adhE* Δ*ldhA* Δ*frdBC* strain was used to increase the NADH available to drive the pathway forward. In this strain where only one of the trans-enoyl-CoA reductases, Td-ter, was overexpressed, there was no 1-hexanol detected, but when both Td-ter and Eg-ter were co-expressed, 23 mg/L 1-hexanol after 68 h was produced in TB supplemented with glucose. To further attempt to increase titer, a strain containing Δ*adhE* Δ*ldhA* Δ*frdBC* Δ*pta* knockouts was first constructed. 1-Hexanol titer using this strain was 27 mg/L after 68 h. Then, *fdh* was overexpressed in a plasmid under control of the P~L~lacO~1~ promoter and pSC101^⋆^ origin ([@B95]) in this knockout strain in order to increase the amount of NADH. In a pH-maintained, anaerobic production where the culture was replenished with fresh TB media every 24 h, production of 1-hexanol at 48 h increased to 47 mg/L. Although 1-hexanol concentrations did not reach those of 1-butanol in this system, further improvements to increase enzymatic activity toward C6 relative to C4 intermediates can be done.

C5--C10 ALCOHOL PRODUCTION VIA β-OXIDATION PATHWAY
==================================================

In contrast to constructing a 1-butanol pathway by overexpressing genes from *C. acetobutylicum*, [@B46] proposed the use of the native aerobic fatty acid β-oxidation cycle commonly found in bacteria and yeast. Normally, these species use this cycle to break down (C~*n*+2~)-acyl-CoA molecules into acetyl-CoA and (C~*n*~)-acetyl CoA molecules using four genes ([@B40]). Since metabolic pathways are essentially reversible, however, 1-butanol could be made after one turn of this cycle (with chain elongation occurring by addition of acetyl-CoA to another thioester). That is, an acetyl-CoA C-acetyltransferase would first condense two acetyl-CoA molecules into acetoacetyl-CoA. Next, a 3-hydroxyacyl-CoA dehydrogenase/enoyl-CoA hydratase would reduce the β-keto acid into 3-hydroxybutyryl-CoA, and subsequently to crotonyl-CoA. Then, crotonyl-CoA would be hydrogenated to a butyryl-CoA, where a native CoA-dependent alcohol/aldehyde dehydrogenase would then convert it into 1-butyraldehyde then 1-butanol in two steps. In an *E. coli* strain containing one chromosomal copy of each gene needed for 1-butanol synthesis (*atoB*, *fadA*, *fadB*, *fadE*, and *adhE*), an artificial genetic element, P~trc-ideal-4~-SDφ10 (containing a strong LacI-dependent promoter as well as a strong ribosome binding site from phage T7), replaced the native regulatory regions of each of the genes in the proposed pathway. When production was tested in semi-aerobic conditions in M9 media ([@B79]) containing glucose and glycerol or LB-containing glucose, 334 and 897 mg/L of 1-butanol was produced, respectively. In addition, 1-butanol in LB was higher, but amount of ethanol produced was the same, and the amount of acetic acid synthesized was lower. On the other hand, in comparison to semi-aerobic conditions, titer was lower in LB (674 mg/L), but higher in M9 media (615 mg/L) under anaerobic conditions.

[@B27] also demonstrated reversal of the β-oxidation cycle to generate higher-chain alcohols and other chemicals. In the presence of a non-fatty acid carbon source, constitutive expression of the fad--ato regulon reversed the beta oxidation cycle ([@B28]). To increase efficiency, repressive regulation of the beta oxidation cycle in the presence of glucose was avoided by using a cAMP-independent mutant (*crp^⋆^*) to replace the native *crp* gene, and by deleting the *arcA* gene in order to eliminate any β-oxidation-encoding operon repression by ArcA (aerobic respiratory control A). In a strain containing these initial genomic modifications in pSC101^⋆^ origin ([@B95]) plasmids under the control of the P~L~tetO~1~ promoter, production of 1-butanol was achieved by overexpression of native *fucO*, encoding a L-1,2-propanediol oxidoreductase, and *yqeF*, encoding an acyl transferase, as well as deletion of the following genes involved in competing pathways: *adhE* (lactate, ethanol, succinate), *pta* (acetate), and *frdA* (succinate), *eutE* and *yqhD* (ethanol). Production in M9 media supplemented with glucose synthesized 2.2 g/L 1-butanol after 24 h at a 28% theoretical yield. When production moved to a bioreactor, however, titer rose to 14 g/L after 36 h at 33% theoretical maximum and a rate of 2 g 1-butanol/g cell dry weight/h. In this pathway, many CoA-thioester intermediates produced could also be converted to the corresponding alcohols and carboxylic acids. By simultaneously overexpressing *tesA* or *tesB* encoding a thioesterase and *yqeF* encoding an acyltransferase, and deleting of both *fadB* encoding an acetyl-CoA C-acetyltransferase and *ydiO* encoding an acyl-CoA dehydrogenase, 150--500 mg/L amounts of various carboxylic acids were produced. Production of longer even-chain *n*-alcohols (C6, C8, and C10) was achieved by utilizing native ADHs (EutG, YiaY, and BetA). Lastly, generation of longer odd-chain *n*-alcohols (C5, C7, and C9) was achieved by overexpressing *yiaY*, encoding a Fe-containing ADH, and supplementing the media with propionate.

[@B15] used consolidated bioprocessing (CBP) ([@B73]) to produce three different biofuels, including 1-butanol, using *E. coli* able to grow on and degrade ionic liquid-pretreated switchgrass ([@B66]), without the addition of exogenous glycoside hydrolases ([@B15]). To degrade cellulose, they found a cellulase, when fused with OsmY, capable of being transported out of *E. coli*. Out of the two OsmY-cellulase fusions, the one that had the highest endocellulase activity was from *Bacillus* sp. D04. To degrade hemicellulose, a previously found endoxylanase from *C. stercorarium*, Xyn10B ([@B93]), was also fused to OsmY. Genes encoding this fusion were under control of a native *P*~cspD~ promoter in a pSC101^⋆^ origin ([@B95]) plasmid. To further break down the cello- and xylodextrins into glucose, a β-glucosidase from *Cellvibrio japonicus*, encoded by *cel3A*, was overexpressed under the control of the native *P*~wrbA~ promoter to degrade cellobiose, while a xylobiosidase from *C. japonicus*, encoded by *gly43F*, was overexpressed under the control of the native *P*~cstA~ promoter in a p15A origin ([@B20]) plasmid to degrade xylodextrins. Resulting plasmids expressing cellulose and hemicellulose breakdown were named pCellulose and pXylan, respectively. By overexpressing a CoA-dependent 1-butanol pathway in an *E. coli* DH1 Δ*adhE* strain, 28 mg/L 1-butanol was produced in EZ-Rich media (Teknova) and 3.3% w/v ionic liquid-pretreated switchgrass as the only carbon source.

2-KETO ACID PATHWAYS FOR C3--C8 ALCOHOLS
========================================

Amino acid pathways are universal, and have also been harnessed for the ease in which amino acid precursors can be rerouted for production C3--C6 alcohols (**Figure [2](#F2){ref-type="fig"}**). The following describes research that emanates from utilization of the last two steps of the Ehrlich pathway ([@B87]) to divert 2-keto acid intermediates to higher-chain alcohols in various hosts.

![**Metabolic representation of 2-keto acid pathways for biofuel production**. G3P, glyceraldehyde-3-phosphate; PEP, phosphoenolpyruvate; AlsS, acetolactate synthase; IlvC, acetohydroxy acid isomeroreductase; IlvD, dihydroxy-acid dehydratase; LeuA, isopropylmalate synthase; LeuB, isopropylmalate dehydrogenase; LeuCD, isopropylmalate dehydratase; CimA, citramalate synthase; 2KIC, 2-ketoisocaproate; 3MB, 3-methyl-1-butanol; 2KIV, 2-ketoisovalerate; 2KB, 2-ketobutyrate; 2KV, 2-ketovalerate; KMV, 2-keto-3-methylvalerate; 2MB, 2-methyl-1-butanol; KMH, 2-keto-4-methylhexanoate; 3MP, 3-methyl-1-pentanol; OAA, oxaloacetate.](fmicb-03-00196-g002){#F2}

[@B7] reported production of several higher-chain alcohols, including isobutanol, 1-butanol, 2-methyl-1-butanol (2MB), 3-methyl-1-butanol (3MB), and 2-phenylethanol, from glucose by engineering the amino acid biosynthetic pathway in *E. coli*. In the pathway, 2-keto acids are converted to the corresponding aldehyde with a 2-keto acid decarboxylase (KDC) and then to the alcohol using an ADH. First, *ADH2* (*S. cerevisiae*) was overexpressed with genes encoding five different KDCs \[Pdc6, Aro10, and Thi3 (*S. cerevisiae*), Kivd (*Lactococcus lactis*), and Pdc (*C. acetobutylicum*)\] in colE origin plasmids under control of the P~L~lacO~1~ promoter to determine which combination gave the highest longer-alcohol titer. Results indicated that Kivd was the most active and had the largest substrate range, and produced all of the expected alcohols. About 22 g/L isobutanol (86% theoretical max) was produced under microaerobic conditions in 112 h by overexpressing *alsS* (*B. subtilis*), *ilvC, ilvD*, *kivd*, and *ADH2*, by introducing Δ*adhE*, Δ*ldhA*, Δ*frdAB*, Δ*fnr*, Δ*pta*, and Δ*pflB* knockouts in order minimize production from competing pathways. Isobutanol has an energy density of 29.0 MJ/L. In addition, about 541 mg/L 1-propanol and 667 mg/L 1-butanol was produced in M9 media (supplemented with glucose) by the non-native alcohol producing pathway. In this pathway, 2-ketobutyrate (2KB), a precursor to isoleucine, is formed via the threonine pathway, and can be converted to 1-propanol using Kivd and Adh2. On the other hand, 2KB can be extended by one carbon using LeuABCD operon to produce the unnatural amino acid norvaline precursor 2-ketovalerate, which can be converted to 1-butanol using the same KDC and ADH.

ISOBUTANOL PRODUCTION VIA THE 2-KETO ACID PATHWAY
=================================================

To improve upon the amino acid-based production of isobutanol, [@B11] compared aerobic isobutanol production in a 1 L bioreactor connected to a gas-stripping system. Using the engineered isobutanol strain ([@B7]), 50 g/L isobutanol was produced in the bioreactor after 72 h (68% maximum theoretical yield) under aerobic conditions and 30°C, which is over twice as high as the 22 g/L produced in a shake flask. By-product production (except acetate) was not detectable. Efforts to knockout several acetate-producing pathways (Δ*ack* Δ*pta* Δ*poxB*), however, did not prevent accumulation of acetate.

Microaerobic conditions have been used to produce isobutanol. For a large-scale production of isobutanol, however, anaerobic production is preferred. A major barrier that must be overcome is NADPH dependency. Since two of the enzymes in the pathway are NADPH-dependent, the pentose phosphate pathway and tricarboxylic acid cycles can regenerate this cofactor only in the presence of oxygen. Under anaerobic conditions, however, NADH is produced as a result of glycolysis. To overcome this cofactor imbalance issue, [@B13] constructed an NADH-dependent pathway by engineering a ketol-acid reductoisomerase IlvC (*E. coli*) and ADH AdhA (*L. lactis*). Directed evolution approaches ([@B83]) were applied to IlvC and AdhA to switch cofactor dependence from NADPH to NADH. In an anaerobic, fully NADH-dependent strain containing AdhA^RE1^ and IlvC^6E6-his6^, 13.4 g/L isobutanol at 100% theoretical maximum yield was produced in M9 media supplemented with glucose, yeast extract, and trace met als (hereafter modified M9). Overexpression of *pntAB*, which enabled reversible transfer of a hydride ion between NADH and NADPH, with *ilvC* and *yqhD* overcame the cofactor imbalance, but produced at a titer and theoretical yield slightly lower than the strain overexpressing NADH-utilizing engineered IlvC^6E6-his6^ and AdhA^RE1^.

Another host used for isobutanol production is the cyanobacterium *S. elongatus* PCC7942, a photosynthetic organism that [@B8] engineered to convert CO~2~ and light energy directly into isobutyraldehyde, a precursor to isobutanol. To install the isobutyraldehyde production pathway *in S. elongatus*,*kivd* (*L. lactis*), under P~trc~ control, was integrated into NSI ([@B18]), and *alsS* (*B. subtilis*), *ilvC*, and *ilvD* (*E. coli*), under P~L~lacO~1~ control, was integrated into NSII ([@B5]) of the genome by homologous recombination ([@B43]). Production in a Roux culture bottle at 30°C and subsequent gas-stripping of isobutyraldehyde resulted in 723 mg/L after 12 days and a production rate of 2,500 μg/L·h. No isobutanol was detected, most likely because the endogenous ADH had no detectable activity toward isobutyraldehyde. One known bottleneck to the pathway is a low activity of ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco) in fixing CO~2~ within the Calvin--Benson--Bassham cycle. To improve isobutyraldehyde production, the *rbcLS* genes from a related *S. elongatus*, PCC6301, was inserted downstream from the endogenous *rbcLS* genes. With an increased Rubisco activity, the resulting strain produced 1.1 g/L isobutyraldehyde after 8 days and a production rate of 6,230 μg/L·h. Isobutanol production was also measured by integrating NADPH-dependent ADH, encoded by *yqhD*, in addition to the isobutyraldehyde pathway. This strain produced 450 mg/L isobutanol after 9 days.

Isobutanol production in Gram-positive *Corynebacterium glutamicum*, an industrial amino acid producer ([@B60]; [@B85]; [@B100]) has also been achieved. [@B91] explored isobutanol production using *C. glutamicum* because *C. glutamicum*was chosen for its rapid growth rate and vast range of tools for genetic manipulation. Furthermore, *C. glutamicum* has been modified to produce L-valine in industrial quantities, and the isobutanol pathway utilizes its precursors. In this system, *alsS* (*B. subtilis*), *ilvC*, *ilvD*, *adhA* (*C. glutamicum*), and *kivd* (*L. lacti*s), in a P~eftu~-controlled, NG2 origin ([@B78]) plasmid, were overexpressed in *C. glutamicum*and resulted in 2.6 g/L isobutanol, 50 mg/L isobutyraldehyde, 0.4 g/L 3MB, as well as other various higher-chain alcohols, after 48 h in CGIII media supplemented with glucose ([@B77]). To prevent direct formation of oxaloacetate from pyruvate, the*pyc*gene (encoding pyruvate carboxylase) was inactivated. In order to inactivate a desired gene in Gram-positive organisms like *C. glutamicum*, a pK-derived mobilizable cloning vector containing a fragment of the gene is first constructed ([@B86]). Then, RP4-mediated conjugation occurs ([@B48]), where the pK-derived plasmid is first incorporated into the genome, then subsequently disrupted. Essentially, a double cross-over event is carried out. As a result of the Δ*pyc* knockout, isobutanol titer increased to 4.3 g/L. Despite this increase, 2.6 g/L of lactate formed. To inhibit formation of lactate from pyruvate and NADH, an additional knockout, Δ*ldh*, which would have encoded lactate dehydrogenase, was introduced. In the highest-producing *C. glutamicum*Δ*pyc*Δ*ldh*knockout strain (containing NG2 origin P~eftu~::*alsS*-*ilvCD-adhA*-*kivd*), 4.9 g/L isobutanol was produced after 120 h (23% theoretical maximum) using a fermenter.

[@B68] engineered *B. subtilis* for production of isobutanol. *B. subtilis* was a host of interest because it was found to have a higher isobutanol tolerance (2%) than both *C. glutamicum*and *E. coli* (1.9- and 3.8-fold, respectively). In a strain containing Δ*amyE* and a two-plasmid system (P~43~::*ilvD*-*ilvC*-*alsS* and P~43~::*kivd*-*adh2*), 2.02 g/L isobutanol was produced after 40 h under 37°C and microaerobic conditions. In addition, lower titers of ethanol, 1-phenylethanol, 2MB, and 3MB were produced. Acetate and lactate were also detected in the production culture. To improve titer, batch and fed-batch fermentations in 1 L shake flasks were performed under microaerobic conditions. After 48 h, the fed-batch fermentation in LB media supplemented with glucose, phosphate buffer, and trace metals produced 2.62 g/L isobutanol at a 0.086 g/L/h production rate.

[@B52] used the cellulolytic mesophile *C. cellulolyticum* to convert crystalline cellulose into isobutanol. *C. cellulolyticum*uses an extracellular, multi-enzymatic cellulosome to breakdown and consume cellulose and other complex polysaccharides efficiently ([@B29]). In a strain overexpressing *kivd*, *yqhD*, *alsS*, *ilvC*, and *ilvD* under the control of a constitutive ferredoxin *C. pasteurianum* promoter, 364 mg/L isobutanol was produced in 90 h from cellobiose, while 660 mg/L isobutanol in 9 days was produced from cellulose. Two major setbacks to the successful production of isobutanol in *C. cellulolyticum* using a CBP platform were (1) lack of an available inducible expression system and the resulting toxicity of gene products, and (2) lack of detectable activity of IlvC and IlvD (due to differences in GC content and codon usage frequencies between *E. coli* and *C. cellulolyticum*).

[@B21] engineered *S. cerevisiae* to produce isobutanol. To construct the pathway, an acetolactate synthase, encoded by *ILV2* (catalytic subunit) and *ILV6* (regulatory subunit), converts two pyruvate molecules into 2-acetolactate, which is subsequently reduced to 2,3-dihydroxyisovalerate by an acetohydroxy acid reductoisomerase, encoded by *ILV5*. Then, 2-ketoisovalerate (2KIV) is produced using a dihydroxyacid dehydratase, encoded by *ILV3*. Next, two branched-chain amino acid aminotransferases, encoded by mitochondrial *BAT1* and cytosolic *BAT2*, reversibly converts 2KIV into L-valine. Afterward, isobutanol is formed using pyruvate decarboxylases (Pdc6, 5, 1) and ADHs. In a strain overexpressing *ILV2*, *ILV3*, and *ILV5* (in plasmids under control of the PGK1 promoter) led to 4.12 mg isobutanol/g glucose when cultivated under aerobic conditions in pH-maintained minimal media supplemented with yeast extract, peptone, dextrose, and 40 g/L glucose. Under anaerobic conditions and minimal media supplemented with 40 g/L glucose, isobutanol yield was 2.13 mg/g glucose in a strain that overexpressed *BAT2* in addition to *ILV2*, *ILV3*, and *ILV5*.

To improve upon the isobutanol titer in *S. cerevisiae*, [@B62] searched for and overexpressed *KDC* and *ADH* genes from different sources. The following three *KDC* enzymes were tested: endogenous phenylpyruvate decarboxylase (Aro10), endogenous 2-ketoisocaproate decarboxylase (Thi3), and 2KIV decarboxylase (Kivd) from *L. lactis*. In addition, six ADH genes from *S. cerevisiae*, encoding for Adh1, Adh2, Adh5, Adh6, Adh7, and Sfa1, were overexpressed in plasmids under control of the PGK1 promoter. Different KDC--ADH combinations were used to measure isobutanol levels under additive additions of 8 g/L 2KIV, the precursor to isobutanol. A *kivd*-*ADH6* combination gave the highest isobutanol level at 488 mg/L, and was used for isobutanol production. To reduce ethanol production, *ILV2* encoding an acetolactate synthase was overexpressed (catalyzes the first committed step in valine biosynthesis from pyruvate). Furthermore, to prevent acetaldehyde production, *pdc1*, which encodes an isozyme of the pyruvate dehydrogenase complex, was deleted. This strain was cultured in synthetic dextrose media supplemented with yeast nitrogen base and glucose, and produced 75 mg/L after 72 h. Under microaerobic conditions, titer rose to 143 mg/L after 120 h at a yield of 6.6 mg/g glucose.

1-PROPANOL AND 1-BUTANOL PRODUCTION VIA THE 2-KETO ACID PATHWAY
===============================================================

[@B90] improved a keto acid-based pathway in *E. coli* to produce 1-propanol (contains an energy density of 27 MJ/L) and 1-butanol from glucose ([@B7]; [@B90]). To deregulate threonine synthesis and increase 2-keto acid intermediates for alcohol production, a feedback-resistant ThrA^fbr^ was used. In addition, several competing pathways were deleted to increase flux toward 2-keto acid production. The final strain containing Δ*metA* Δ*tdh* Δ*ilvB* Δ*ilvI* Δ*adhE* and overexpression of *thrA*^fbr^BC, *ilvA*, *leuABCD*(*E. coli*), *kivd* (*L. lactis*), and *ADH2* (*S. cerevisiae*), in p15A ([@B20]) or colE ([@B57]) origin plasmids and all under the control of the P~L~lacO~1~ promoter, produced 2 g/L 1:1 coproduction of 1-butanol and 1-propanol after 72 h in modified M9 media under anaerobic conditions.

[@B9] improved production of 1-propanol and 1-butanol by evolving a citramalate synthase (CimA) from the extreme thermophile *Methanococcus jannaschii*. CimA is a homolog of LeuA that implements a more direct route than the threonine pathway toward 2KB. In addition, bypassing the threonine pathway to generate 2KB (Δ*ilvA* and Δ*tdcB*) eliminates the liberation of NH~3~ due to deamination of threonine. CimA catalyzes the addition of an acetyl group from acetyl-CoA onto pyruvate to synthesize citramalate, which then undergoes transformations catalyzed by LeuBCD to produce 2KB. 1-Propanol and 1-butanol can then be produced using the same enzymes expressed by *kivd* (*L. lactis*) and *ADH2* (*S. cerevisiae*; [@B7]). To improve activity of CimA toward pyruvate, several rounds of random mutagenesis and DNA shuffling were used to mutate the *cimA* gene, and improved variants were screened for using a growth-based selection. That is, in a strain containing Δ*ilvA* and Δ*tdcB*, isoleucine cannot be produced, and thus the strain cannot grow, unless CimA is active in the cell. The strain containing the evolved *cimA*, overexpressed in a P~L~lacO~1~-controlled, p15A origin ([@B20]) plasmid, anaerobically produced 2.8 g/L 1-propanol and 393 mg/L 1-butanol after 40 h at 30°C in modified M9 media.

3-METHYL-1-BUTANOL PRODUCTION VIA THE 2-KETO ACID PATHWAY
=========================================================

[@B24] took advantage of native amino acid biosynthetic pathways to produce 3MB, another higher-chain alcohol with an energy density of 30.5 MJ/L, in *E. coli* from glucose. To produce 3MB, the *ilvIHCD* genes were overexpressed to convert pyruvate into 2KIV, a precursor to the amino acid valine, which can be converted to 2-ketoisocaproate, a precursor to the amino acid leucine, by LeuABCD enzymes. Finally, 2-ketoisocaproate can then be redirected by Kivd and Adh2 to produce 3MB. The initial strain produced 56 mg/L 3MB after 18 h in modified M9 media under anaerobic conditions at 30°C. To increase 3MB titer, several modifications were introduced. First, *alsS* (*B. subtilis*), previously shown to increase isobutanol production via valine synthesis, was overexpressed in place of *ilvIH* in a pSC101 origin ([@B95]) plasmid under P~L~lacO~1~ control ([@B72]). To increase production of 2KIV, the *leuABCD* genes were overexpressed in a colE origin ([@B57]), P~L~lacO~1~-controlled plasmid. Furthermore, genes expressing enzymes involved in competing pathways were deleted (Δ*adhE* Δ*frdBC* Δ*ldhA* Δ*pta* Δ*fnr* Δ*pflB* Δ*ilvE* Δ*tyrB*) from the genome. Lastly, a feedback-insensitive LeuA^fbr^ ([@B47]) was used to deregulate leucine synthesis and increase flux toward 2-ketoisocaproate. The final strain produced 1.28 g/L 3MB (0.11 g/g yield) and 0.2 g/L isobutanol after 28 h under anaerobic conditions.

Expanding upon the 3MB pathway ([@B24]), [@B23] performed several rounds of random whole-cell mutagenesis with *N*-methyl-*N*′-nitro-*N*-nitrosoguanidine and selection with amino acid analog 4-aza-d,L-leucine (AZL) to produce a 3MB hyper-producer. If the cell can outcompete production of this L-leucine analog by producing much more natural L-leucine -- in turn increasing production of 3MB precursor 2-ketoisocaproate -- then the cell will circumvent the occurrence of fatal incorporation of AZL into polypeptides. Therefore, selecting for mutants able to adapt to the addition of toxic levels of AZL by elevating production of natural amino acids should increase 3MB titer. Using a mutant able to outcompete production of AZL, 4.4 g/L 3MB was produced with a theoretical yield of 30% after 36 h in under anaerobic conditions. In addition to mutagenesis and selection for higher 3MB producers, a two-phase fermentation strategy with oleyl alcohol was implemented in order to separate 3MB from the production phase and minimize toxic concentrations of 3MB, thus extending production lifetime of the engineered 3MB hyper-producer. Using this approach with a mutated 3MB strain resulted in a titer of 9.6 g/L at 33% theoretical maximum after 60 h. Further analysis of the two-phase culture revealed that 90% of 3MB and 80% of isobutanol produced was present in the oleyl alcohol phase.

2-METHYL-1-BUTANOL PRODUCTION VIA THE 2-KETO ACID PATHWAY
=========================================================

[@B19] demonstrated the production of 2MB, a branched-chain alcohol with an energy density of 30.5 MJ/L, via the precursor for isoleucine, 2-keto-3-methylvalerate (KMV), in *E. coli* from glucose. In this study, different isozymes of key enzymes along the constructed 2MB pathway were tested and selected based on 2MB versus 1-propanol titer. Both 2MB and 1-propanol are derivatives of 2-keto acids, and involve the use of a broad-substrate range KDC to convert the corresponding 2-keto acid into an aldehyde, then reduce it into the alcohol using an ADH. Further, an acetohydroxy acid synthase (AHAS) catalyzes the first step in isoleucine synthesis, where 2KB and pyruvate are condensed to make 2-aceto-2-hydroxybutyrate, a precursor to 2MB. Therefore, an ideal AHAS for 2MB production was chosen based on how well it outcompeted KDC for 2KB. If the AHAS outcompetes KDC, then 2MB production would be favored over 1-propanol production. First, several AHAS isozymes were tested for rate of conversion of 2KB to 2MB versus 1-propanol. It was found that AHAS II (encoded by *ilvGM*) from *Salmonella typhimurium* produced the highest amount of 2MB and minimal 1-propanol in modified M9 media supplemented with 8 g/L 2KB. Next, various threonine deaminase isozymes were overexpressed in p15A origin ([@B20]) plasmids under P~L~lacO~1~ control to analyze how well supplied L-threonine is consumed and converted into 2MB and 1-propanol. The strain containing the best threonine deaminase coded by *ilvA* (*C. glutamicum*) converted about 88% of supplied L-threonine into 2MB and 1-propanol. Then, the threonine pathway was overexpressed (*thrABC*). Lastly, several combinations of Δ*metA* Δ*tdh* Δ*ilvB* Δ*ilvI* Δ*leuA* and Δ*ilvE* deletions were tested for 2MB production. The best combination was determined to be Δ*metA* and Δ*tdh*, which eliminated carbon flux toward methionine and consumption of threonine, respectively. The resulting *E. coli* strain produced, from glucose, 1.25 g/L 2MB (44% theoretical maximum) in 24 h at 30°C under anaerobic conditions.

C6--C8 ALCOHOL PRODUCTION VIA THE 2-KETO ACID PATHWAY
=====================================================

[@B102] expanded the 2-keto acid-based pathway for the production of higher-chain alcohols (C \> 5) by using structure-based protein engineering to expand the substrate range of 2-isopropylmalate synthase (LeuA) and 2KIV decarboxylase (Kivd) from *L. lactis*, which are both already known to be promiscuous enzymes. First, Kivd was engineered to be more selective toward 2-keto-4-methylhexanoate, a non-natural precursor of 3-methyl-1-pentanol. To do this, a sequence alignment was done on indolepyruvate decarboxylase (IPDC) of *Enterobacter cloacae* and pyruvate decarboxylase (PDC) from *Zymomonas mobilis*, each having a 40 and 31% homology to Kivd, respectively. Investigation of residues within the keto acid-binding pocket of each enzyme led to an F381L/V461A Kivd variant. To engineer LeuA, sequence alignment of LeuA from *S. typhimurium* and *Mycobacterium tuberculosis* showed 92 and 21% homology to that of *E. coli*, respectively. In addition to the G462D point mutation to deregulate valine synthesis, S139G mutation was inserted to accommodate the extra methyl group (S)-2-keto-3-methylvalerate contains. In an *E. coli* strain containing both Kivd and LeuA mutants, 793.5 mg/L 3-methyl-1-pentanol was produced in modified M9 media. Additional point mutations into smaller amino acids in Kivd were included to accommodate larger keto acid intermediates. Specifically, the addition of an N167A point mutation to the double mutant allowed for the production of 51.9 mg/L 4-methyl-1-hexanol. Moreover, incorporation of H97A to the triple mutant resulted in production of 57.3 mg/L 4-methyl-1-hexanol, as well as 22.0 mg/L 5-methyl-1-heptanol.

[@B75] modified LeuA further with structure-based protein engineering to increase its promiscuity toward larger 2-keto acids. These larger 2-keto acids, in turn, can be directed toward higher-chain alcohol production (C \> 5). Furthermore, quantum mechanical modeling and protein--substrate complex modeling were used to simulate and analyze the different transition states of the carbon--carbon bond forming steps that are catalyzed by candidate LeuA variants (LeuA^⋆^) in order to determine the best conformers. Using this approach, mutants that cater to a 2-keto acid of interest can be predicted, whether it contains an aromatic, linear-chained, or branched-chain group. In a threonine hyperproducer strain containing a Δ*rhtA* (encoding threonine transporter gene), and three plasmid \[with pSC101 ([@B95]), p15A ([@B20]), or colE ([@B57]) replication origin\], P~L~lacO~1~-controlled ([@B72]) overexpression of *thrABC* (threonine pathway genes), *ilvA* (*B. subtilis*) *leuA^⋆^BCD*, *kivd* (F381L/V461A, *L. lactis*), and *ADH6* (*S. cerevisiae*), production of C4--C8 alcohols in modified M9 media was measured. There were four notable LeuA^⋆^ variants. LeuA^⋆^ containing S139G/G462D produced 993 mg/L and 2.22 g/L 1-butanol and 1-pentanol, respectively. LeuA^⋆^ H97A/S139G/G462D produced 302 mg/L 1-hexanol. Lastly, LeuA^⋆^ H97A/S139G/P169A/G462D produced 80 and 2 mg/L 1-heptanol and 1-octanol, respectively.

PROTEIN CONVERSION TO C4--C5 ALCOHOLS
=====================================

Apart from the use of glucose as a feedstock for biofuel production, [@B54] explored the use of protein biomass as a potential feedstock. *E. coli* was engineered to generate protein hydrolysates in order to breakdown proteins in three exogenous transamination and deamination cycles from bacteria, yeast, and microalgae into amino acids, which can then be converted to the corresponding 2-keto acid intermediates, and finally into C2--C6 alcohols by mimicking the Ehrlich pathway. Any reduced nitrogen, i.e., NH~3~, produced is excreted irreversibly from the cell, and can be collected and recycled as fertilizer. In addition, leftover amino acids can be used as raw material for various chemicals and pharmaceutical intermediates, or as a supplement for animal feedstocks. The final strain \[YH19Δ*glnA*Δ*gdhA*Δ*lsrA* overexpressing *alsS*, *ilvC*, *ilvD*, and *avtA* in a p15A origin ([@B20]), P~L~lacO~1~-controlled ([@B72]) plasmid, *kivD*, *yqhD*, *leuDH*, and *ilvE*, in a colE origin ([@B57]), P~L~lacO~1~-controlled plasmid, and *sdaB* and *ilvA*in a pSC101 origin ([@B95]), P~L~lacO~1~-controlled plasmid\] produced 4 g/L C4 and C5 alcohols at 56% theoretical yield from amino acids.

ISOPENTENOL PRODUCTION VIA THE MEVALONATE ISOPRENOID PATHWAY
============================================================

Isoprenoids have a vast range of uses, including for nutraceuticals, therapeutics, polymers, and fragrances. They are hydrocarbons that stem from isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) precursors, which are produced from acetyl-CoA or pyruvate and glyceraldehyde-3-phosphate using the mevalonate ([@B44]) or methylerythritol ([@B69]) pathways, respectively. The mevalonate isoprenoid pathway has been engineered and exploited for production of isopentenol from acetyl-CoA.

To produce isopentenol from isoprenoid precursors IPP and DMAP (**Figure [3](#F3){ref-type="fig"}**), [@B101] first used a growth-based phenotype to screen a library of isoprene synthases from *B. subtilis*6051 based on ability to minimize toxic levels of prenyl diphosphates by converting them into prenyl alcohols. One of two genes isolated from a pool of 19,000 clones, *nudF*, was overexpressed in a colE origin ([@B57]) plasmid under control of a native *Bacillus* promoter in conjunction with the mevalonate pathway plasmids pMevT (p15 origin) and pMBI (Bbr origin) in the previously optimized *E. coli* DH1 strain ([@B76]), and produced 110 mg/L isopentenol after 43 h at 30°C under aerobic conditions in 250 mL shake flasks containing M9 media supplemented with 3-(*N*-morpholino)propanesulfonic acid, glucose, and yeast extract.

![**Metabolic representation of mevalonate isoprenoid pathway for biofuel production**. AtoB, acetyl-CoA thiolase; HGMS, HMG-CoA synthase; tHGMR, truncated HMG-CoA reductase; ERG12, mevalonate kinase; ERG8, phosphomevalonate kinase; IPP, isopentenyl diphosphate; Idi, IPP isomerase; DMAP, dimethylallyl diphosphate; NudF, ADP-ribose pyrophosphatase.](fmicb-03-00196-g003){#F3}

CONCLUSION
==========

The evolving field of synthetic biology has helped widen the range of modular possibilities in which cell system and behavior can be modified, and will continue to be an influence in the development and improvement of biological methods for biofuel production. In recent years, there has been a growing number of biotech companies that are applying these methods in order to produce higher-chain alcohols commercially. Namely, both Gevo and Butamax have industrialized isobutanol production platforms. But as titers in an engineered host continue to elevate (**Table [1](#T1){ref-type="table"}**), and experimental yields start to match up with theoretical maximums, the resulting increase in productivity comes with a price.

###### 

Highest reported higher-chain alcohol titers in *E. coli*.

  Higher-chain alcohol   Titer (g/L)   Reference
  ---------------------- ------------- -----------
  1-Propanol             2.8           [@B9]
  Isopropanol            143           [@B55]
  1-Butanol              30            [@B89]
  Isobutanol             50            [@B11]
  1-Pentanol             2.22          [@B75]
  Isopentenol            0.11          [@B76]
  2-Methyl-1-butanol     1.25          [@B19]
  3-Methyl-1-butanol     9.6           [@B24]
  1-Hexanol              0.047         [@B26]
  3-Methyl-1-pentanol    0.794         [@B102]
  1-Heptanol             0.08          [@B75]
  4-Methyl-1-hexanol     0.057         [@B102]
  5-Methyl-1-hexanol     0.022         [@B102]

One prominent barrier is the toxic accumulation of the target molecule that stunts cell fitness during production, which, in turn, can hinder a newly engineered strain from producing at industrial-relevant titers. Thus, increasing the product tolerance of, as well as simultaneous product removal from, a host is desirable. Fortunately, there are several approaches that have been developed to help mitigate toxicity levels during the production phase ([@B103]; [@B10]; [@B34]; [@B31]). There is, however, much to be elucidated about the convoluted physiological effects that occur in a host when exposed to elevated levels of a final product.

Development of a process to breakdown biomass effectively and efficiently is also vital to decreasing production time and costs. Until then, CBP is yet another approach worth considering in increasing titer, yield, and productivity. A unified production platform in which biomass can be broken down efficiently and subsequently converted into fuel can be practical, especially if paired with product removal methods. Meanwhile, development of a production platform that uses sunlight and CO~2~ directly, such as cyanobacteria and microalgae is well worth the effort, and is yet another approach that should be considered in biofuel research. Especially, this approach circumvents the need for a biomass source, and can be cultivated in non-arable areas, i.e., oceans and deserts.

The race to reach a renewable fuel production level of 36 billion gallons by 2022 continues as the production of advanced biofuels gains momentum. For 2012, the Renewable Fuel Standard (RFS2) has established a goal to produce 15.2 billion gallons of biofuels, which already approaches half the mandate for 2022. Although the process to become independent from petroleum-derived fuels is still in its initial stages, efforts to increase synergy between all aspects of strain design, development, optimization, and execution for renewable higher-chain alcohols and other liquid fuel production in non-native hosts will be a great aid in leading the way toward a permanent turn of tables.
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